Previous Article | Next Article ![]()
Infect. Immun., 05 1996, 1600-1608, Vol 64, No. 5
JP Burnie, W Brooks, M Donohoe, S Hodgetts, A al-Ghamdi and RC Matthews
Immunoblotting of sera from 12 neutropenic patients with Streptococcus
oralis septicemia and 18 patients with endocarditis due to viridans group
streptococci revealed immunodominant S. oralis antigens at 85 and 180 kDa.
The former cross-reacted with a mouse monoclonal antibody to hsp90. The
latter was identified by sequencing positive clones obtained by screening a
genomic expression library of S. oralis with pooled sera from patients who
had been infected with S. oralis. Antibody eluted from one of these clones
reacted with the 180-kDa antigen of S. oralis. Southern blotting confirmed
the origin of the clone from S. oralis. The derived amino acid sequence
showed 76.2% homology with the PAc protein precursor of Streptococcus
mutans and 73.8% homology with the SpaA protein precursor of Streptococcus
sobrinus. Epitope mapping of the derived amino acid sequence with sera from
patients with viridans group streptococcal endocarditis delineated nine
epitopes. Peptides 1 (TMYPNRQPGSGWDSS) and 2 (WYSLNGKIRAVDVPK),
representing two of these epitopes, and peptide 3 (YEVEKPLEPAPVAPS),
representing the repeat proline region, were synthesized. These three
peptides were used to screen a phage antibody display library derived from
a patient who had recovered from S. oralis infection. Two of the human
recombinant antibodies produced (SORAL 3 and SORAL 4 against peptide 3) and
a human recombinant antibody (B3.7) against the conserved epitope (LKVIRK)
of hsp90 gave statistically significant protection, compared with control
groups, in a mouse model of lethal S. oralis infection.
Copyright © 1996, American Society for Microbiology
Defining antibody targets in Streptococcus oralis infection
University Department of Medical Microbiology, Manchester Healthcare Trust, United Kingdom.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|